| # | Pathway | Proteins |
|---|
| 1 | Ribosome | ENSAPLP00000008397, ENSAPLP00000003321, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000001900 |
| 2 | Malaria | ENSAPLP00000016307, ENSAPLP00000007488 |
| 3 | African trypanosomiasis | ENSAPLP00000016307, ENSAPLP00000007488 |
| 4 | Mineral absorption | ENSAPLP00000009906, ENSAPLP00000015679 |
| 5 | Arginine and proline metabolism | ENSAPLP00000008767, ENSAPLP00000007097 |
| 6 | Protein digestion and absorption | ENSAPLP00000000463, ENSAPLP00000000439 |
| 7 | Estrogen signaling pathway | ENSAPLP00000013972, ENSAPLP00000014548 |
| 8 | Protein processing in endoplasmic reticulum | ENSAPLP00000000419, ENSAPLP00000010630, ENSAPLP00000014548 |
| 9 | Systemic lupus erythematosus | ENSAPLP00000001729, ENSAPLP00000001720 |
| 10 | Vitamin digestion and absorption | ENSAPLP00000011529 |
| 11 | Histidine metabolism (no map in kegg database) | ENSAPLP00000008767 |
| 12 | Alcoholism | ENSAPLP00000001729, ENSAPLP00000001720 |
| 13 | Fat digestion and absorption | ENSAPLP00000011529 |
| 14 | Bladder cancer | ENSAPLP00000013972 |
| 15 | ECM-receptor interaction | ENSAPLP00000000463, ENSAPLP00000000439 |
| 16 | NOD-like receptor signaling pathway | ENSAPLP00000014548 |
| 17 | TGF-beta signaling pathway | ENSAPLP00000013831 |
| 18 | PI3K-Akt signaling pathway | ENSAPLP00000000463, ENSAPLP00000000439, ENSAPLP00000014548 |
| 19 | beta-Alanine metabolism (no map in kegg database) | ENSAPLP00000008767 |
| 20 | Lysine degradation | ENSAPLP00000010985 |
| 21 | Amyotrophic lateral sclerosis (ALS) | ENSAPLP00000012498 |
| 22 | TNF signaling pathway | ENSAPLP00000013972 |
| 23 | Transcriptional misregulation in cancer | ENSAPLP00000013972 |
| 24 | Thyroid hormone synthesis | ENSAPLP00000014548 |
| 25 | Ribosome biogenesis in eukaryotes | ENSAPLP00000006775 |
| 26 | Glutathione metabolism | ENSAPLP00000007097 |
| 27 | Prostate cancer | ENSAPLP00000014548 |
| 28 | Cardiac muscle contraction | ENSAPLP00000012136 |
| 29 | Proteoglycans in cancer | ENSAPLP00000013972, ENSAPLP00000013831 |
| 30 | Complement and coagulation cascades | ENSAPLP00000010484 |
| 31 | Hepatitis B | ENSAPLP00000013972 |
| 32 | HIF-1 signaling pathway | ENSAPLP00000015679 |
| 33 | Hypertrophic cardiomyopathy (HCM) | ENSAPLP00000012136 |
| 34 | Dilated cardiomyopathy | ENSAPLP00000012136 |
| 35 | Adrenergic signaling in cardiomyocytes | ENSAPLP00000012136 |
| 36 | Focal adhesion | ENSAPLP00000000463, ENSAPLP00000000439 |
| 37 | Amoebiasis | ENSAPLP00000012216 |
| 38 | MicroRNAs in cancer | ENSAPLP00000013972 |
| 39 | Leukocyte transendothelial migration | ENSAPLP00000013972 |
| 40 | Pathways in cancer | ENSAPLP00000013972, ENSAPLP00000014548 |
| 41 | Parkinson's disease | ENSAPLP00000006744 |
| 42 | Viral carcinogenesis | ENSAPLP00000001720 |
| 43 | Metabolic pathways (no map in kegg database) | ENSAPLP00000008767, ENSAPLP00000007097 |